| Literature DB >> 20460535 |
Siquan Chen1, Jonathan L Blank, Theodore Peters, Xiaozhen J Liu, David M Rappoli, Michael D Pickard, Saurabh Menon, Jie Yu, Denise L Driscoll, Trupti Lingaraj, Anne L Burkhardt, Wei Chen, Khristofer Garcia, Darshan S Sappal, Jesse Gray, Paul Hales, Patrick J Leroy, John Ringeling, Claudia Rabino, James J Spelman, Jay P Morgenstern, Eric S Lightcap.
Abstract
Multiple pathways have been proposed to explain how proteasome inhibition induces cell death, but mechanisms remain unclear. To approach this issue, we performed a genome-wide siRNA screen to evaluate the genetic determinants that confer sensitivity to bortezomib (Velcade (R); PS-341). This screen identified 100 genes whose knockdown affected lethality to bortezomib and to a structurally diverse set of other proteasome inhibitors. A comparison of three cell lines revealed that 39 of 100 genes were commonly linked to cell death. We causally linked bortezomib-induced cell death to the accumulation of ASF1B, Myc, ODC1, Noxa, BNIP3, Gadd45alpha, p-SMC1A, SREBF1, and p53. Our results suggest that proteasome inhibition promotes cell death primarily by dysregulating Myc and polyamines, interfering with protein translation, and disrupting essential DNA damage repair pathways, leading to programmed cell death. Copyright 2010 AACR.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20460535 DOI: 10.1158/0008-5472.CAN-09-4428
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701